Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Advances Late-stage Development of Its Differentiated CD38 Antibody Felzartamab (TJ202) in China 2021-10-13 20:00
AUM Biosciences announces closing of USD $27Million in a "Series A" Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies 2021-10-13 02:30
NeoPlex (TM) HPV29 Detection, a new molecular detection kit from Genematrix, acquires European CE-IVD certification 2021-10-12 16:00
ProfoundBio Announces Presentation on Novel, Proprietary Linker-Drug Technology to Enable Antibody-Drug Conjugates (ADCs) with an Expanded Therapeutic Window at the AACR-NCI-EORTC International Conference 2021-10-08 11:39
Amplo Biotechnology Closes Series Seed Financing to Advance Gene Therapies for The Treatment of Neuromuscular Junction Disorders 2021-10-06 23:30
I-Mab Announces Upcoming Participation at October Conferences 2021-10-01 20:00
Binhai sets ambitious biomedical goals with support of key companies 2021-10-01 01:08
Penn mRNA Biology Pioneer Drew Weissman Joins RVAC's Science Advisory Board 2021-10-01 00:50
I-Mab Reports Multiple Positive Clinical Updates of Differentiated CD47 Antibody Lemzoparlimab 2021-09-30 20:00
GenFleet and Innovent Starts First-in-human Phase I/II Trial of KRAS G12C Inhibitor 2021-09-30 08:05
Neurophth Announces the Completion of GMP Manufacturing Facility for Gene Therapy Products According to International Standards 2021-09-27 23:00
Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase III Trial in Patients with Generalized Myasthenia Gravis 2021-09-27 21:03
Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference 2021-09-27 19:20
Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002 2021-09-27 08:30
GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target 2021-09-26 22:28
Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platform and CEA/CD3 Bispecific Antibody at World Bispecific Summit 2021-09-26 10:12
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA 2021-09-24 09:18
The First US World-Class Bioscience Design Corporation Officially Launched 2021-09-23 09:00
Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest 2021-09-22 18:56
Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA 2021-09-22 18:00
1 80 81 82 83 84 204